
CHGCY
Healthcare · Drug Manufacturers - General · $74.08B market cap
$22.50+0.32 (+1.4%)Nov 13, 3:52 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 27, 2026 | After the close | — | 0.27 | — |
| Jul 24, 2026 | After the close | — | 0.22 | — |
| Apr 24, 2026 | After the close | — | 0.22 | — |
| Jan 29, 2026 | After the close | — | 78.02 | — |
| Oct 24, 2025 | After the close | — | 0.23 | — |
| Jul 24, 2025 | After the close | — | 0.20 | — |
| Apr 24, 2025 | Before the open | — | 0.19 | — |
| Jan 30, 2025 | Before the open | — | 0.18 | — |
| Oct 25, 2024 | Before the open | — | 0.22 | — |
| Jul 25, 2024 | Before the open | — | 0.22 | — |
| Apr 24, 2024 | Before the open | — | 0.15 | — |
| Mar 27, 2024 | After the close | — | 0.19 | — |
| Sep 30, 2021 | Time not confirmed | — | 0.47 | — |
| Jun 30, 2021 |
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Lunsumio, Perjeta, Phesgo, Polivy, and Tecentriq; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept,…
| Time not confirmed |
| — |
| 0.39 |
| — |
| Mar 31, 2021 | Time not confirmed | — | 0.26 | — |
| Dec 31, 2020 | Time not confirmed | — | 0.31 | — |
| Jul 26, 2020 | After the close | 31.33 | 30.89 | -1.4% |
| Apr 23, 2020 | Time not confirmed | 30.27 | 31.37 | +3.6% |
| Jan 29, 2020 | After the close | 24.83 | 24.46 | -1.5% |
| Oct 24, 2019 | Time not confirmed | 20.80 | 29.31 | +40.9% |
| Jul 24, 2019 | After the close | 17.73 | 20.84 | +17.5% |
| Apr 24, 2019 | Time not confirmed | 18.57 | 21.34 | +14.9% |
| Jan 30, 2019 | After the close | — | 13.49 | — |
| Oct 24, 2018 | Time not confirmed | 13.93 | 13.20 | -5.2% |
| Jul 25, 2018 | After the close | 10.93 | 12.67 | +15.9% |
| Apr 23, 2018 | After the close | 47.30 | 51.00 | +7.8% |
| Jan 31, 2018 | After the close | 33.26 | 28.38 | -14.7% |